Variables | Total | 3-month mortality | P-value | 6-month mortality | P-value | 1-year Mortality | P-value | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No | Yes | No | Yes | No | Yes | ||||||||||||
Total | 1,975 | (100.0) | 1,498 | (75.8) | 477 | (24.2) | Â | 1,191 | (60.3) | 784 | (39.7) | Â | 836 | (42.3) | 1,139 | (57.7) | Â |
Healthcare Vulnerability |  |  |  |  |  |  |  < .0001 |  |  |  |  | 0.0003 |  |  |  |  | 0.0180 |
 Vulnerable region | 279 | (14.1) | 184 | (65.9) | 95 | (34.1) |  | 141 | (50.5) | 138 | (49.5) |  | 100 | (35.8) | 179 | (64.2) |  |
 Non-vulnerable region | 1,696 | (85.9) | 1,314 | (77.5) | 382 | (22.5) |  | 1,050 | (61.9) | 646 | (38.1) |  | 736 | (43.4) | 960 | (56.6) |  |
Pancreatic Cancer Treatment |  |  |  |  |  |  |  < .0001 |  |  |  |  |  < .0001 |  |  |  |  |  < .0001 |
 Yes | 860 | (43.5) | 795 | (92.4) | 65 | (7.6) |  | 676 | (78.6) | 184 | (21.4) |  | 455 | (52.9) | 405 | (47.1) |  |
 No | 1,115 | (56.5) | 703 | (63.0) | 412 | (37.0) |  | 515 | (46.2) | 600 | (53.8) |  | 381 | (34.2) | 734 | (65.8) |  |
Sex | Â | Â | Â | Â | Â | Â | 0.3964 | Â | Â | Â | Â | 0.7728 | Â | Â | Â | Â | 0.5420 |
 Male | 1,093 | (55.3) | 821 | (75.1) | 272 | (24.9) |  | 656 | (60.0) | 437 | (40.0) |  | 456 | (41.7) | 637 | (58.3) |  |
 Female | 882 | (44.7) | 677 | (76.8) | 205 | (23.2) |  | 535 | (60.7) | 347 | (39.3) |  | 380 | (43.1) | 502 | (56.9) |  |
Age |  |  |  |  |  |  |  < .0001 |  |  |  |  |  < .0001 |  |  |  |  |  < .0001 |
  < 50 | 173 | (8.8) | 157 | (90.8) | 16 | (9.2) |  | 138 | (79.8) | 35 | (20.2) |  | 122 | (70.5) | 51 | (29.5) |  |
 50–60 | 311 | (15.7) | 275 | (88.4) | 36 | (11.6) |  | 234 | (75.2) | 77 | (24.8) |  | 163 | (52.4) | 148 | (47.6) |  |
 60–70 | 503 | (25.5) | 415 | (82.5) | 88 | (17.5) |  | 350 | (69.6) | 153 | (30.4) |  | 251 | (49.9) | 252 | (50.1) |  |
 70–80 | 598 | (30.3) | 431 | (72.1) | 167 | (27.9) |  | 320 | (53.5) | 278 | (46.5) |  | 217 | (36.3) | 381 | (63.7) |  |
  > 80 | 390 | (19.7) | 220 | (56.4) | 170 | (43.6) |  | 149 | (38.2) | 241 | (61.8) |  | 83 | (21.3) | 307 | (78.7) |  |
Household income | Â | Â | Â | Â | Â | Â | 0.7841 | Â | Â | Â | Â | 0.3680 | Â | Â | Â | Â | 0.2443 |
 Low | 437 | (22.1) | 326 | (74.6) | 111 | (25.4) |  | 251 | (57.4) | 186 | (42.6) |  | 171 | (39.1) | 266 | (60.9) |  |
 Mid-low | 621 | (31.4) | 474 | (76.3) | 147 | (23.7) |  | 377 | (60.7) | 244 | (39.3) |  | 275 | (44.3) | 346 | (55.7) |  |
 Mid-high | 917 | (46.4) | 698 | (76.1) | 219 | (23.9) |  | 563 | (61.4) | 354 | (38.6) |  | 390 | (42.5) | 527 | (57.5) |  |
Medical Insurance | Â | Â | Â | Â | Â | Â | 0.8633 | Â | Â | Â | Â | 0.5623 | Â | Â | Â | Â | 0.2294 |
 Insurance Coverage (Regional) | 639 | (32.4) | 480 | (75.1) | 159 | (24.9) |  | 381 | (59.6) | 258 | (40.4) |  | 262 | (41.0) | 377 | (59.0) |  |
 Insurance Coverage (corporate) | 1,279 | (64.8) | 975 | (76.2) | 304 | (23.8) |  | 779 | (60.9) | 500 | (39.1) |  | 555 | (43.4) | 724 | (56.6) |  |
 Medical Aid | 57 | (2.9) | 43 | (75.4) | 14 | (24.6) |  | 31 | (54.4) | 26 | (45.6) |  | 19 | (33.3) | 38 | (66.7) |  |
Disorder | Â | Â | Â | Â | Â | Â | 0.0355 | Â | Â | Â | Â | 0.0168 | Â | Â | Â | Â | 0.0339 |
 No | 1,828 | (92.6) | 1,397 | (76.4) | 431 | (23.6) |  | 1,116 | (61.1) | 712 | (38.9) |  | 786 | (43.0) | 1,042 | (57.0) |  |
 Yes | 147 | (7.4) | 101 | (68.7) | 46 | (31.3) |  | 75 | (51.0) | 72 | (49.0) |  | 50 | (34.0) | 97 | (66.0) |  |
CCI | Â | Â | Â | Â | Â | Â | 0.0003 | Â | Â | Â | Â | 0.0269 | Â | Â | Â | Â | 0.8036 |
 0 | 353 | (17.9) | 262 | (74.2) | 91 | (25.8) |  | 211 | (59.8) | 142 | (40.2) |  | 145 | (41.1) | 208 | (58.9) |  |
 1–2 | 885 | (44.8) | 708 | (80.0) | 177 | (20.0) |  | 561 | (63.4) | 324 | (36.6) |  | 381 | (43.1) | 504 | (56.9) |  |
  ≥ 3 | 737 | (37.3) | 528 | (71.6) | 209 | (28.4) |  | 419 | (56.9) | 318 | (43.1) |  | 310 | (42.1) | 427 | (57.9) |  |